2016-08-15 14:24 ET - News Release OKLAHOMA CITY -- (Business Wire) On July 25, 2016, a class action lawsuit was filed in the United States District Court for the Central District of California against CytRx Corporation (NASDAQ: CYTR). Federman & ... Stockwatch, 2 weeks ago
Federman & Sherwood : Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against CytRx Corporation - 4 Traders, 2 weeks ago
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against CytRx Corporation - Sys-Con Media, 4 weeks ago
Federman & Sherwood Investigates ZIOPHARM Oncology, Inc. for Possible Violations of Federal Securities Laws
OKLAHOMA CITY--(Business Wire)--The law firm of Federman & Sherwood has initiated an investigation into ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) with respect to possible violations of federal securities laws. ZIOPHARM Oncology, Inc. (ZIOPHARM) is a ...Digital Journal, 1 month ago Federman & Sherwood : Investigates ZIOPHARM Oncology, Inc. for Possible Violations of Federal Securities Laws 4 Traders, 1 month ago Law Firm Investigates Signet for Possible Federal Securities Law Violations Rough Polished, 2 months ago
Preliminary evidence, based on brain scans (MRI) and neurocognitive assessments at 24 weeks, showed the potential for disease stabilization in patients with MPS IIIB treated with SBC-103.1 These data were presented at the 14th International ...Equilibrio Informativo, 1 month ago
GlobalData Accelerate Diagnostics, Inc. (AXDX) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to ...MarketResearch.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!